menu
    • menu

    Company profile for Siegfried AG

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    SERVICES

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    As an internationally renowned outsourcing partner, we offer products and tailor-made service packages that are seamlessly embedded in the value chain of our customers. Our pharmaceutical industry partners benefit from a wide range of offers - from the development of active ingredients to development services for ready-made drugs, their approval and production to packaging and logistics. As a former fully integrated pharmaceut...
    As an internationally renowned outsourcing partner, we offer products and tailor-made service packages that are seamlessly embedded in the value chain of our customers. Our pharmaceutical industry partners benefit from a wide range of offers - from the development of active ingredients to development services for ready-made drugs, their approval and production to packaging and logistics. As a former fully integrated pharmaceutical company, Siegfried is now one of the few suppliers who can develop both active ingredients and ready-made drugs under one roof. This combination of experience and know-how is unique in the CDMO market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Siegfried AGSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Untere Bruehlstrasse 4, 4800 Zofingen
    Telephone
    Telephone
    +41 62 746 1111
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.siegfried.ch/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/siegfried-holding-ag
    youtube
    YouTube
    Twitter
    Twitter
    https://twitter.com/siegfried_group?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI Worldwide, Milan

    CPhI Worldwide, Milan

    Not Confirmed

    envelop Contact Supplier

    CPhI Worldwide, Milan

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “We’re unlocking life-changing potential in complex molecules, without sacrificing time to market”

    “We’re unlocking life-changing potential in complex molecules, without sacrificing time to market”

    This week, SpeakPharma interviews Mike Riley, CEO of Veranova, a leading contract development and manufacturing organization (CDMO) confidently mastering complex APIs as it marks its second year as an independent company. Riley discusses Veranova’s key achievements, including a US$ 30 million investment in their Devens, Massachusetts (US) site to expand capabilities in antibody-drug conjugates (ADCs) and highly potent APIs (HPAPIs), and how it is navigating the increasing complexity of molecules. 🔑 HIGHLIGHTS// Veranova’s key achievements / navigating the increasing complexity of molecules Veranova is celebrating its second year as a stand-alone company. Can you share Veranova’s key milestones and achievements in its first two years? We have achieved incredible milestones over the last two years, thanks to the dedication and hard work of our team. Our first 12 months focused on establishing ourselves as an independent CDMO by building on the 50 years of expertise that we brought with us. In addition, we expanded our capabilities and applied a more agile approach available to us as a company singularly focused on life sciences. This has allowed us to move into our second year with clear and strategic goals for generating growth in our sites, people, capabilities, and offerings. Since being appointed as CEO in May 2023, I’ve had the pleasure of witnessing some exciting growth milestones of my own. Most recently, we announced an estimated US$ 30 million investment in our Devens, Massachusetts, site. This expansion will allow us to build upon existing development and manufacturing capabilities in ADCs and HPAPIs that will address the growing demand for strong US-based capacity in these key drug modalities. We also appointed our Advisory Board, thereby bolstering Veranova’s in-house expertise. Made up of four distinguished leaders in pharma and biopharma – including Dr. Carolyn Bertozzi, the 2022 Nobel Laureate in Chemistry – the Board has provided thought-leadership, guidance and expertise as we develop and execute our strategic growth and ideas. We were also proud to be recognized as one of the Society of Chemical Manufacturers and Affiliates’ 12 companies for industry-leading safety programs in 2023 and as a part of the Medicine Maker’s Power List in 2024. 🔑 HIGHLIGHTS// US$ 30 million investment in our Devens, Massachusetts, site / appointed our Advisory Board Molecules are becoming increasingly complex. Can you elaborate on how Veranova’s current capabilities are strategically designed to address this trend in the coming years? The pharmaceutical pipeline is witnessing an increasing number of complex and highly potent molecules. This trend is driven by the demand for more targeted, patient-centric therapeutics and the focus on innovative modalities such as ADCs and other bioconjugates. At Veranova, our expertise, world-class facilities, and scientific excellence enable us to provide our customers with the clarity and solutions needed to manage this development and manufacturing complexity and ultimately deliver the required treatments to customers and patients. Our people are key to this approach. We have an expert team ready to collaborate with customers at any point, from early development through large-scale commercial production. Our services include world-leading crystallization development, process development, and specialized manufacturing expertise for complex synthetic molecules, including those requiring chromatography capabilities. In many cases, we can provide all these under one roof. Our service offering to our customers is also based on the foundational element of strong quality and compliance systems. We operate multiple facilities approved by the US FDA, UK’s MHRA and other regulatory authorities and are continually focused on ways to strengthen our global quality management system. Looking ahead, we are focused on continually investing in our facilities and team to meet growing complexity, as evidenced by our recent announcement of new investment in our Devens site. This investment signals our commitment to providing state-of-the-art capacity and capabilities to enable these next-generation therapies to reach patients. It is a key milestone as we advance Veranova’s broader growth strategy. 🔑 HIGHLIGHTS// provide our customers with clarity and solutions / world-leading crystallization development / expertise for complex synthetic molecules / strong quality and compliance systems How is Veranova approaching the challenge of designing and manufacturing effective linker molecules for ADCs? As a leader in complex linker-payload synthesis, Veranova is committed to unlocking the life-changing potential of ADCs without letting their complexities slow down the development of much-needed cancer therapies. ADCs are intricate, multi-component molecules that require extensive expertise and agile collaboration to overcome unique development challenges. With over a decade of experience in ADC linker-payload systems, we have developed the ability to anticipate challenges and avoid common pitfalls. The ADC linker-payload components are complex structures that are difficult to crystallize and require specialized high-potent handling. Veranova’s differentiated combination of world-leading crystallization development capabilities, complex synthesis experience, chromatography expertise and high-potent-handling experience put us in a unique position to solve these challenges for customers and speed their products to the clinic. We prioritize getting it right the first time, minimizing change orders and ensuring high-quality results. We have developed a robust phase-appropriate strategy that is backed by state-of-the-art analytical equipment and regulatory procedures to ensure our partners can rapidly progress their ADC projects from pre-clinical to commercialization. 🔑 HIGHLIGHTS// unlocking the life-changing potential of ADCs / ensuring our partners can rapidly progress their ADC projects Can you specify how Veranova is using artificial intelligence (AI) to optimize manufacturing processes that can reduce costs and environmental footprint as well as speed up development? In May 2024, Veranova announced a partnership with Phorum.AI to leverage AI to optimize pharmaceutical manufacturing processes. This collaboration aims to enable the rapid development of processes that can drive efficiency and reduce costs while maximizing environmental sustainability. Our goal is to combine Veranova’s extensive empirical manufacturing dataset of owned APIs and drug master files with Phorum.AI’s computational chemistry engine in order to create a more powerful process-development tool for the benefit of Veranova’s and Phorum’s customers. At Veranova, we are constantly looking to employ innovative technologies and approaches to improve efficiency, accelerate time to market and reduce environmental footprint. We have the means to work with a variety of partners who have unique project requirements, without sacrificing time to market.  🔑 HIGHLIGHTS// partnership with Phorum.AI / create a more powerful process-development tool / improve efficiency, accelerate time to market and reduce environmental footprint

    Impressions: 1975

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market

    #SpeakPharma With Veranova
    10 Sep 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    The US is in the midst of yet another, or perhaps the most, polarizing Presidential election. The two candidates have highly divergent personas, records, visions and views. That gets reflected in their starkly different visions for the healthcare system.Healthcare is the second most important issue for voters in the 2024 US elections, with only the economy ranking higher, according to the Pew Research Center.In this week’s PharmaFlow, we look at the past approaches of both the contenders — Democratic presidential nominee Kamala Harris and Republican contender Donald Trump — towards healthcare, and what the two presidencies could mean for the US healthcare industry.Both Harris and Trump have a rare point of agreement — that the US government should act on reducing high drug prices. But have they spelt out how they will make healthcare more accessible? Our analysis should give you some answers.Abortion remains a pivotal issue, may shape broader discussions on healthcareTrump takes pride in the fact that he played an important role in overturning Roe v. Wade, a ruling that protected the abortion rights of women across America. Trump did that by selecting Supreme Court justices who were instrumental in overturning it. Two and a half years after Roe v. Wade was overturned, Trump faces an electorate that largely seems to favor abortion rights — according to Pew Research, 63 percent respondents say abortion should be legal in all or most cases, while 36 percent say it should be illegal in all or most cases.Candidates’ stances on abortion access, including the regulation on medications like mifepristone, are being scrutinized by both supporters and opponents of abortion rights. In June this year, the US Supreme Court had unanimously rejected a case to restrict access to the abortion drug mifepristone. The demand for its ban had been raised by an anti-abortion group in Texas.Of late, there have been reports of Republicans trying to distance themselves from aggressive anti-abortion ideas coming from its party men and allies. Aiming to carve-out a political middle ground, Trump has said that abortion policy should be made by the states. Despite Trump’s softening of stance, abortion rights is likely to not only affect voter turnout, but also shape broader discussions on healthcare and women’s rights.Affordable Care Act: Harris to strengthen it, Trump has ‘concepts of a plan’ to replace itHarris has been all for expanding and strengthening the Affordable Care Act (ACA). She has promised to “make affordable healthcare a right, not a privilege.”Trump, on the other hand, had made attempts during his presidency to repeal and replace the ACA, arguing that it provided “lousy healthcare.” While those efforts ultimately failed in the Senate, Trump succeeded in weakening the ACA by eliminating the individual mandate penalty through the 2017 Tax Cuts and Jobs Act.In a potential second term, Trump might renew efforts to dismantle or significantly alter the ACA. Although he has not presented a comprehensive replacement plan, he said during the Presidential debate held on September 9 that he has “concepts of a plan.”Drug prices: Harris to accelerate Medicare price cuts; Trump to focus on genericsHarris has had an aggressive stance on reducing prescription drug costs. Her tie-breaking vote on the Inflation Reduction Act gave Medicare the power to negotiate lower drug prices with pharmaceutical companies.Harris has pledged to accelerate those negotiations, once she becomes President, to cover more drugs and further lower prices for Americans. She also intends to extend the US$ 35 cap on insulin and the US$ 2,000 cap on out-of-pocket spending for seniors to all Americans, not just those on Medicare.Harris plans to make permanent the Biden-Harris tax credit enhancements that have already lowered healthcare premiums by an average of about US$ 800 a year for millions of Americans. This move would ensure continued accessibility to health insurance for a broader segment of the population.However, her stance on insurance companies and Big Pharma, including her support for “march-in” rights, might face resistance from pharmaceutical companies concerned about maintaining incentives for innovation.On the issue of drug pricing, Trump’s record is mixed. While he took credit for some decreases in prescription drug prices during his presidency, his administration’s most significant regulatory changes often favored pharmaceutical companies.Trump did issue a rule setting up a path to import drugs from Canada and other countries, but this initiative has faced significant hurdles, including pushback from Canadian authorities.Trump’s stance on drug pricing for a potential second term appears to focus on increasing generic and biosimilar competition, importing drugs made in the US but sold overseas back to the US, and capping out-of-pocket insulin costs. While he has criticized Big Pharma for putting profits above people, his administration’s policies had often aligned with industry interests.Harris appears committed to drug control; Trump had cut public health fundsMental health and substance abuse are the other areas where Harris has shown strong commitment. Having prosecuted drug traffickers, she has demonstrated her commitment to curbing the opioid epidemic.In the White House, she helped direct more than US$ 150 billion to disrupt the flow of illicit drugs and delivered billions of dollars in investments to states to fund lifesaving programs. Under a Harris administration, we might see increased funding for addiction treatment programs and continued efforts to make overdose-reversal drugs like naloxone more accessible.During his presidency, Trump had significantly reduced funding for public health programs. His administration had suggested budget cuts to the Centers for Disease Control and Prevention (CDC) and other public health agencies, justifying them as measures for fiscal responsibility.Our viewGiven her record, a Harris presidency could lead to increased insurance coverage. However, it might also come with increased regulation and price controls. More aggressive drug price negotiations could pressure pharmaceutical companies’ profit margins, potentially affecting R&D budgets. Stricter vigilance on the pharmaceutical industry could lead to more litigation and regulatory challenges for drug companies. But in the long run, this might also improve public trust in drug companies and in the healthcare systems.Under a second Trump term, reduced public health funding could create challenges for community health providers and public health initiatives. An emphasis on generic competition could pressure brand-name drug manufacturers, but create opportunities for generic drug makers.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 518

    https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices

    #Phispers by PHARMACOMPASS
    26 Sep 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Marcel Imwinkelried appointed as new CEO
    Marcel Imwinkelried appointed as new CEO

    10 Jul 2024

    // PRESS RELEASE

    https://www.siegfried.ch/marcel-imwinkelried-appointed-as-new-ceo/

    PRESS RELEASE
    10 Jul 2024
    Share Share
    Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US)
    Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US)

    02 Jul 2024

    // PRESS RELEASE

    Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US)

    PRESS RELEASE
    02 Jul 2024
    Share Share
    EGS's sexercises right to convert bond & increases its shareholding Siegfried
    EGS's sexercises right to convert bond & increases its shareholding Siegfried

    14 Jun 2024

    // PRESS RELEASE

    https://www.siegfried.ch/egs-beteiligungen-ag-exercises-right-to-convert-bond-and-increases-its-shareholding-in-siegfried-to-6-2-registered-shares/

    PRESS RELEASE
    14 Jun 2024
    Share Share
    Siegfried expands US reach with deal for Wisconsin facility
    Siegfried expands US reach with deal for Wisconsin facility

    13 Jun 2024

    // Joseph Keenan FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/cdmo-siegfried-expands-us-footprint-acquisition-wisconsin-facility

    Joseph Keenan FIERCE PHARMA
    13 Jun 2024
    Share Share
    Siegfried to acquire an early-phase CDMO in (US) for its Drug Sub services
    Siegfried to acquire an early-phase CDMO in (US) for its Drug Sub services

    12 Jun 2024

    // PRESS RELEASE

    https://www.siegfried.ch/siegfried-to-acquire-an-early-phase-cdmo-in-wisconsin-us-to-strengthen-its-drug-substances-service-offering/

    PRESS RELEASE
    12 Jun 2024
    Share Share
    Siegfried increases distribution to the shareholders & all proposals of the BOD
    Siegfried increases distribution to the shareholders & all proposals of the BOD

    15 Apr 2024

    // PRESS RELEASE

    https://www.siegfried.ch/siegfried-increases-distribution-to-the-shareholders-and-all-proposals-of-the-board-of-directors-are-approved/

    PRESS RELEASE
    15 Apr 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Buprenorphine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BioProcess International
    Not Confirmed
    arrow

    Buprenorphine

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BioProcess International
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-05-16

    Pay. Date : 2013-01-28

    DMF Number : 26052

    Submission : 2012-05-14

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2024-312 - Rev 00

    Issue Date : 2024-08-21

    Type : Chemical

    Substance Number : 1180

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 305MF10007

    Registrant's Address : Karlstrasse 15, 32423, Minden, Federal Republic of Germany

    Initial Date of Registration : 2023-01-18

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 0792-0631

    Start Marketing Date : 2015-02-27

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Caffeine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BioProcess International
    Not Confirmed
    arrow

    Caffeine

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BioProcess International
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2012-11-04

    Pay. Date : 2012-12-14

    DMF Number : 5032

    Submission : 1983-08-05

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1998-022 - Rev 03

    Issue Date : 2015-12-15

    Type : Chemical

    Substance Number : 267

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 217MF10988

    Registrant's Address : Karlstrasse 15, 32423, Minden, Federal Republic of Germany

    Initial Date of Registration : 2005-11-21

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 65724-4000

    Start Marketing Date : 2000-02-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : CTC Bio Co., Ltd.

    Registration Date : 2022-08-08

    Registration Number : 20220808-211-J-1341

    Manufacturer Name : Siegfried PharmaChemikalien Minden GmbH

    Manufacturer Address : Karlstraße 15-39, 42-44 32423 Minden, Germany

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Dobutamine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BioProcess International
    Not Confirmed
    arrow

    Dobutamine Hydrochloride

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BioProcess International
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 11023

    Submission : 1994-08-02

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2006-273 - Rev 01

    Issue Date : 2015-12-15

    Type : Chemical

    Substance Number : 1200

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 217MF10990

    Registrant's Address : Karlstrasse 15, 32423, Minden, Federal Republic of Germany

    Initial Date of Registration : 2005-11-21

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : CTC Bio Co., Ltd.

    Registration Date : 2021-11-23

    Registration Number : 20211123-210-J-1157

    Manufacturer Name : Siegfried PharmaChemikalien Minden GmbH

    Manufacturer Address : Karlstraße 15-39, 42-44 32423 Minden, Germany

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Dopamine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BioProcess International
    Not Confirmed
    arrow

    Dopamine

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BioProcess International
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 3116

    Submission : 1977-12-27

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2007-049 - Rev 01

    Issue Date : 2015-12-15

    Type : Chemical

    Substance Number : 664

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10519

    Registrant's Address : Karlstrasse 15, 32423, Minden, Federal Republic of Germany

    Initial Date of Registration : 2006-05-18

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 65724-4500

    Start Marketing Date : 2009-06-11

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Mepivacaine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BioProcess International
    Not Confirmed
    arrow

    Mepivacaine Hydrochloride

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BioProcess International
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 3469

    Submission : 1979-01-10

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2001-305 - Rev 04

    Issue Date : 2018-11-08

    Type : Chemical

    Substance Number : 1242

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10524

    Registrant's Address : Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland

    Initial Date of Registration : 2006-05-18

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 17381-261

    Start Marketing Date : 2010-04-15

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Oxybuprocaine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BioProcess International
    Not Confirmed
    arrow

    Oxybuprocaine Hydrochloride

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BioProcess International
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 5024

    Submission : 1983-06-28

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2022-104 - Rev 00

    Issue Date : 2023-08-31

    Type : Chemical

    Substance Number : 1251

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 304MF10112

    Registrant's Address : Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland

    Initial Date of Registration : 2022-08-03

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 17381-253

    Start Marketing Date : 2010-05-11

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Prilocaine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BioProcess International
    Not Confirmed
    arrow

    Prilocaine

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BioProcess International
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-03-19

    Pay. Date : 2013-08-13

    DMF Number : 14144

    Submission : 1999-05-12

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2002-227 - Rev 08

    Issue Date : 2021-02-24

    Type : Chemical

    Substance Number : 1362

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 222MF10085

    Registrant's Address : Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland

    Initial Date of Registration : 2010-03-16

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 17381-017

    Start Marketing Date : 2010-04-22

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Prilocaine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BioProcess International
    Not Confirmed
    arrow

    Prilocaine Hydrochloride

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BioProcess International
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-11-13

    Pay. Date : 2014-10-23

    DMF Number : 5019

    Submission : 1983-06-29

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2002-170 - Rev 06

    Issue Date : 2021-02-24

    Type : Chemical

    Substance Number : 1363

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 219MF10013

    Registrant's Address : Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland

    Initial Date of Registration : 2007-01-18

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 17381-249

    Start Marketing Date : 2010-04-22

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Primidone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BioProcess International
    Not Confirmed
    arrow

    Primidone

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BioProcess International
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2023-03-28

    Pay. Date : 2023-03-23

    DMF Number : 2199

    Submission : 1973-12-07

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1996-101 - Rev 06

    Issue Date : 2020-02-07

    Type : Chemical

    Substance Number : 584

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 306MF10004

    Registrant's Address : No. 5, Tongshun Road, Nantong Economic & Technological Development Area, Nantong, Jiangsu Province, P. R. C.

    Initial Date of Registration : 2024-01-11

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 17205-307

    Start Marketing Date : 1973-12-07

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Tetracaine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    BioProcess International
    Not Confirmed
    arrow

    Tetracaine Hydrochloride

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    BioProcess International
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 4065

    Submission : 1981-02-20

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2017-205 - Rev 01

    Issue Date : 2024-01-29

    Type : Chemical

    Substance Number : 57

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 220MF10198

    Registrant's Address : Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland

    Initial Date of Registration : 2008-09-09

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 17381-100

    Start Marketing Date : 2010-05-18

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    Analytical

    Click here to discover the service providers for Analytical

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    Capsule

    read-more
    read-more

    01

    CAPSULE MANUFACTURING

    CAPSULE MANUFACTURING

    arrow
    BioProcess International
    Not Confirmed

    02

    HARD GELATIN CAPSULE

    HARD GELATIN CAPSULE

    arrow
    BioProcess International
    Not Confirmed
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Packaging

    Click here to discover the service providers for Packaging

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    BioProcess International
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioProcess International
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2008-12-19

    Siegfried AG

    City : Pennsville

    State : NJ

    Country/Area : US

    Zip : 08070-3244

    District : NWJ

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2008-12-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    BioProcess International
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioProcess International
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2008-12-19

    Siegfried AG

    City : Pennsville

    State : NJ

    Country/Area : US

    Zip : 08070-3244

    District : NWJ

    Center : CVM

    Project Area : Monitoring of Marketed Animal Dr...

    District Decision : No Action Indicated

    Inspection End Date : 2008-12-19

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    BioProcess International
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioProcess International
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2011-03-30

    Siegfried AG

    City : Pennsville

    State : NJ

    Country/Area : US

    Zip : 08070-3244

    District : NWJ

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2011-03-30

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    BioProcess International
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioProcess International
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2011-03-30

    Siegfried AG

    City : Pennsville

    State : NJ

    Country/Area : US

    Zip : 08070-3244

    District : NWJ

    Center : CVM

    Project Area : Monitoring of Marketed Animal Dr...

    District Decision : No Action Indicated

    Inspection End Date : 2011-03-30

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    BioProcess International
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioProcess International
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-02-06

    Siegfried AG

    City : Pennsville

    State : NJ

    Country/Area : US

    Zip : 08070-3244

    District : NWJ

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-02-06

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    BioProcess International
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioProcess International
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-02-06

    Siegfried AG

    City : Pennsville

    State : NJ

    Country/Area : US

    Zip : 08070-3244

    District : NWJ

    Center : CVM

    Project Area : Monitoring of Marketed Animal Dr...

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-02-06

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    FDA Audited

    USA
    BioProcess International
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioProcess International
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-03-26

    Siegfried AG

    City : Pennsville

    State : NJ

    Country/Area : US

    Zip : 08070-3244

    District : NWJ

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-03-26

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    FDA Audited

    USA
    BioProcess International
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioProcess International
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-05-15

    Siegfried AG

    City : Pennsville

    State : NJ

    Country/Area : US

    Zip : 08070-3244

    District : NWJ

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2014-05-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    09

    FDA Audited

    USA
    BioProcess International
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioProcess International
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2014-05-15

    Siegfried AG

    City : Pennsville

    State : NJ

    Country/Area : US

    Zip : 08070-3244

    District : NWJ

    Center : CVM

    Project Area : Monitoring of Marketed Animal Dr...

    District Decision : No Action Indicated

    Inspection End Date : 2014-05-15

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    10

    FDA Audited

    USA
    BioProcess International
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    BioProcess International
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2010-07-29

    Siegfried AG

    City : Zofingen

    State :

    Country/Area : CH

    Zip :

    District : ORA

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2010-07-29

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Siegfried AG and get a quotation

    Siegfried AG is a supplier offers 190 products (APIs, Excipients or Intermediates).

    Find a price of Buprenorphine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Caffeine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Dobutamine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Dopamine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Mepivacaine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Nicotine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Oxybuprocaine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Oxybutynin Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Prilocaine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Prilocaine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Primidone bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Tetracaine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Theophylline bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Oxymetazoline Hydrochloride bulk with CEP, JDMF offered by Siegfried AG

    Find a price of Articaine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Bupivacaine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Buprenorphine bulk with DMF, CEP offered by Siegfried AG

    Find a price of Buprenorphine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Carbachol bulk with DMF, CEP offered by Siegfried AG

    Find a price of Carbamazepine bulk with DMF, CEP offered by Siegfried AG

    Find a price of Fluoxetine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Hydromorphone Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Isotretinoin bulk with DMF, CEP offered by Siegfried AG

    Find a price of Methadone Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Naloxone Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Naltrexone Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Nicotine bulk with DMF, CEP offered by Siegfried AG

    Find a price of Phenylephrine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Pseudoephedrine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Ribavirin bulk with DMF, JDMF offered by Siegfried AG

    Find a price of Theophylline bulk with DMF, CEP offered by Siegfried AG

    Find a price of Tretinoin bulk with DMF, CEP offered by Siegfried AG

    Find a price of Xylometazoline Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Amitriptyline Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Amorolfine Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Fluoxetine Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Methylphenidate Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Morphine Sulfate bulk with CEP offered by Siegfried AG

    Find a price of Nifedipine bulk with CEP offered by Siegfried AG

    Find a price of Oxycodone Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Selegiline Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Sotalol Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Acemetacin bulk with CEP offered by Siegfried AG

    Find a price of Alitretinoin bulk with DMF offered by Siegfried AG

    Find a price of Aminophylline bulk with CEP offered by Siegfried AG

    Find a price of Amobarbital Sodium bulk with DMF offered by Siegfried AG

    Find a price of Amphetamine bulk with DMF offered by Siegfried AG

    Find a price of Amphetamine Aspartate bulk with DMF offered by Siegfried AG

    Find a price of Amylmetacresol bulk with CEP offered by Siegfried AG

    Find a price of Aprepitant bulk with JDMF offered by Siegfried AG

    Find a price of Benzonatate bulk with DMF offered by Siegfried AG

    Find a price of Bethanechol bulk with DMF offered by Siegfried AG

    Find a price of Bupivacaine bulk with DMF offered by Siegfried AG

    Find a price of Buprenorphine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Butalbital bulk with DMF offered by Siegfried AG

    Find a price of Carbamazepine bulk with DMF offered by Siegfried AG

    Find a price of Carisoprodol bulk with DMF offered by Siegfried AG

    Find a price of Chlorobutanol Hemihydrate bulk with DMF offered by Siegfried AG

    Find a price of Chloroprocaine HCl bulk with DMF offered by Siegfried AG

    Find a price of Choline Salicylate bulk with DMF offered by Siegfried AG

    Find a price of Cinchocaine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Codeine Phosphate bulk with DMF offered by Siegfried AG

    Find a price of Dexmethylphenidate bulk with DMF offered by Siegfried AG

    Find a price of Dextroamphetamine Saccharate bulk with DMF offered by Siegfried AG

    Find a price of Ephedrine bulk with DMF offered by Siegfried AG

    Find a price of Ephedrine Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Ephedrine Sulfate bulk with DMF offered by Siegfried AG

    Find a price of Felbamate bulk with DMF offered by Siegfried AG

    Find a price of Fosinopril bulk with CEP offered by Siegfried AG

    Find a price of Hydrocodone Bitartrate bulk with DMF offered by Siegfried AG

    Find a price of Levomethadone bulk with CEP offered by Siegfried AG

    Find a price of Levonordefrin bulk with DMF offered by Siegfried AG

    Find a price of Mefloquine bulk with DMF offered by Siegfried AG

    Find a price of Methenamine Hippurate bulk with DMF offered by Siegfried AG

    Find a price of Metolazone bulk with DMF offered by Siegfried AG

    Find a price of Naloxone Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Nsc241225 bulk with JDMF offered by Siegfried AG

    Find a price of Oxiconazole Nitrate bulk with DMF offered by Siegfried AG

    Find a price of Oxybutynin bulk with DMF offered by Siegfried AG

    Find a price of Oxycodone Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Oxycodone Hydrochloride bulk offered by Siegfried AG

    Find a price of Oxymetazoline Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Phenelzine Sulfate bulk with DMF offered by Siegfried AG

    Find a price of Phenobarbital bulk with DMF offered by Siegfried AG

    Find a price of Phentermine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Primidone bulk with JDMF offered by Siegfried AG

    Find a price of Proparacaine hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Ritalinic Acid bulk with DMF offered by Siegfried AG

    Find a price of Selegiline Hydrochloride bulk offered by Siegfried AG

    Find a price of Tetracaine bulk with CEP offered by Siegfried AG

    Find a price of Tetracaine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Ticlopidine bulk with JDMF offered by Siegfried AG

    Find a price of Tilidine bulk with CEP offered by Siegfried AG

    Find a price of Topiramate bulk with JDMF offered by Siegfried AG

    Find a price of Trimethobenzamide HCl bulk with DMF offered by Siegfried AG

    Find a price of Venlafaxine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Xylometazoline Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of ENAMINE AMIDE bulk with DMF offered by Siegfried AG

    Find a price of Acetylcholine Chloride bulk offered by Siegfried AG

    Find a price of Acemetacin bulk offered by Siegfried AG

    Find a price of Allopurinol bulk offered by Siegfried AG

    Find a price of Alphacetylmethadol bulk offered by Siegfried AG

    Find a price of Amiloride Hydrochloride bulk offered by Siegfried AG

    Find a price of Apazone bulk offered by Siegfried AG

    Find a price of Benzomethamine bulk offered by Siegfried AG

    Find a price of Benzphetamine bulk offered by Siegfried AG

    Find a price of Bismuth Subsalicylate bulk offered by Siegfried AG

    Find a price of Candeptin bulk offered by Siegfried AG

    Find a price of Cascara bulk offered by Siegfried AG

    Find a price of Clopidogrel bulk offered by Siegfried AG

    Find a price of Codeine bulk offered by Siegfried AG

    Find a price of Codeine Sulfate bulk offered by Siegfried AG

    Find a price of Cyproheptadine Hydrochloride bulk offered by Siegfried AG

    Find a price of Deserpidine bulk offered by Siegfried AG

    Find a price of Desvenlafaxine Succinate bulk offered by Siegfried AG

    Find a price of Dextropropoxyphene bulk offered by Siegfried AG

    Find a price of Dextropropoxyphene HCl bulk offered by Siegfried AG

    Find a price of Dibenzosuberenone bulk offered by Siegfried AG

    Find a price of Dibenzsuberone bulk offered by Siegfried AG

    Find a price of Dihydrocodeine Tartrate bulk offered by Siegfried AG

    Find a price of Diltiazem Hydrochloride bulk offered by Siegfried AG

    Find a price of Diphenoxylate Hydrochloride bulk offered by Siegfried AG

    Find a price of Divalproex Sodium bulk offered by Siegfried AG

    Find a price of Gemfibrozil bulk offered by Siegfried AG

    Find a price of Glycopyrronium Bromide bulk offered by Siegfried AG

    Find a price of Gramicidin bulk offered by Siegfried AG

    Find a price of Hydralazine Hydrochloride bulk offered by Siegfried AG

    Find a price of Hydroxyzine Dihydrochloride bulk offered by Siegfried AG

    Find a price of Inositol niacinate bulk offered by Siegfried AG

    Find a price of Irbesartan bulk offered by Siegfried AG

    Find a price of Isoxsuprine Hydrochloride bulk offered by Siegfried AG

    Find a price of Khellin bulk offered by Siegfried AG

    Find a price of Mephenoxalone bulk offered by Siegfried AG

    Find a price of Mephobarbital bulk offered by Siegfried AG

    Find a price of Methacholine Chloride bulk offered by Siegfried AG

    Find a price of Metoprolol Tartrate bulk offered by Siegfried AG

    Find a price of Morphine Sulfate bulk offered by Siegfried AG

    Find a price of Narphen bulk offered by Siegfried AG

    Find a price of Neomycin bulk offered by Siegfried AG

    Find a price of Neomycin Sulfate bulk offered by Siegfried AG

    Find a price of Nimodipine bulk offered by Siegfried AG

    Find a price of Nitrendipine bulk offered by Siegfried AG

    Find a price of Omoconazole bulk offered by Siegfried AG

    Find a price of Oxcarbazepine bulk offered by Siegfried AG

    Find a price of Oxycodone Terephthalate bulk offered by Siegfried AG

    Find a price of Oxymorphone Hydrochloride bulk offered by Siegfried AG

    Find a price of Pethidine Hydrochloride bulk offered by Siegfried AG

    Find a price of Phenazopyridine bulk offered by Siegfried AG

    Find a price of Phenprobamate bulk offered by Siegfried AG

    Find a price of Pholcodine bulk offered by Siegfried AG

    Find a price of Propafenone Hydrochloride bulk offered by Siegfried AG

    Find a price of Propoxyphene Napsylate bulk offered by Siegfried AG

    Find a price of Quercetin bulk offered by Siegfried AG

    Find a price of Rescinnamine bulk offered by Siegfried AG

    Find a price of Reserpine bulk offered by Siegfried AG

    Find a price of Rutin bulk offered by Siegfried AG

    Find a price of SECOBARBITAL SODIUM bulk offered by Siegfried AG

    Find a price of Sodium Valproate bulk offered by Siegfried AG

    Find a price of Sulfiram bulk offered by Siegfried AG

    Find a price of Triamterene bulk offered by Siegfried AG

    Find a price of Tyrothricin bulk offered by Siegfried AG

    Find a price of Venlafaxine Hydrochloride bulk offered by Siegfried AG

    Find a price of Xipamide bulk offered by Siegfried AG

    Find a price of VERABORE--SPECIAL AMORPHOUS ALKALOIDS OF VERATRUM VIRIDE bulk offered by Siegfried AG

    Find a price of AMMOIDIN (8-METHOXYPSORALEN, XANTHATOXIN) bulk offered by Siegfried AG

    Find a price of ORGANIZATION MFG SITE BUILDING FACILITIES AND OPERATION OF FACTORY IN TAOYUAN TAIWAN ROC bulk offered by Siegfried AG

    Find a price of AQUEESTROL bulk offered by Siegfried AG

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN TAIPEI, TAIWAN. bulk offered by Siegfried AG

    Find a price of N-ACETYL PROCAINAMIDE HCL bulk offered by Siegfried AG

    Find a price of UTERASE bulk offered by Siegfried AG

    Find a price of PHTHALAMAQUIN bulk offered by Siegfried AG

    Find a price of OPIUM TINCTURE SOLUTION bulk offered by Siegfried AG

    Find a price of OPIUM TINCTURE, 2% bulk offered by Siegfried AG

    Find a price of RAUSERFIA TABLETS bulk offered by Siegfried AG

    Find a price of PROTAVERATRINE bulk offered by Siegfried AG

    Find a price of Amirophylline bulk offered by Siegfried AG

    Find a price of Cyclizine bulk offered by Siegfried AG

    Find a price of Levonordefrin Hydrochloride bulk offered by Siegfried AG

    Find a price of Metacaine bulk offered by Siegfried AG

    Find a price of Methadone bulk offered by Siegfried AG

    Find a price of Methylphenidate bulk offered by Siegfried AG

    Find a price of Naltrexone bulk offered by Siegfried AG

    Find a price of Naltrexone Methobromide bulk offered by Siegfried AG

    Find a price of Nicotine bulk offered by Siegfried AG

    Find a price of Pentobarbital Sodium bulk offered by Siegfried AG

    Find a price of Phenobarbital Sodium bulk offered by Siegfried AG

    Find a price of Phentermine bulk offered by Siegfried AG

    Find a price of Pseudoephedrine Sulfate bulk offered by Siegfried AG

    Find a price of Tapentadol bulk offered by Siegfried AG

    Find a price of Theophylline Monohydrate bulk offered by Siegfried AG

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search